ADAM12: a potential target for the treatment of chronic wounds - Wikidata - wikimedia - TriplyDB

ADAM12: a potential target for the treatment of chronic wounds

ADAM12: a potential target for the treatment of chronic wounds

http://www.wikidata.org/entity/Q37173718

about

Induction of specific microRNAs inhibits cutaneous wound healing Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12 Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers The Roles of ADAMs Family Proteinases in Skin Diseases Alternative mRNA splicing generates two distinct ADAM12 prodomain variants.ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis Quality assessment of tissue specimens for studies of diabetic foot ulcers.A modeling approach to study the effect of cell polarization on keratinocyte migration.Comparative Genomic, MicroRNA, and Tissue Analyses Reveal Subtle Differences between Non-Diabetic and Diabetic Foot Skin.Characteristics and clinical managements of chronic skin ulcers based on traditional chinese medicine.Genetic predictors of susceptibility to cutaneous fungal infections: a pilot genome wide association study to refine a candidate gene search.Biology and Biomarkers for Wound Healing.Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9.Skinomics: past, present and future for diagnostic microarray studies in dermatology.Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.Genetic Predictors of Susceptibility to Dermatophytoses.Epithelialization in Wound Healing: A Comprehensive Review.Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis.

P2860

Q28578955-9DC56716-912D-4E0C-A354-089323F7541A Q30360467-6BB560D9-4DAF-434E-BB02-72BA035F1A34 Q33581718-CB2B5F6D-58AB-4B7F-81FB-003870FF09A5 Q34669802-53CFCDC5-259E-4045-8B25-A3B5E76D7474 Q35014541-7A9BB7E9-5CB8-438C-9FA1-5B1F364C5EBD Q35063483-B000AC4B-9C0C-4320-967B-C55B19C93E71 Q35146497-6F2F5EBD-E034-49D2-A569-D3E55862B9BC Q35559326-74859178-DB4D-49D4-B949-47400F1A3A30 Q35759270-6C8418E2-429F-4043-9C6E-AC0C59D8F973 Q35986836-7BE67923-0406-4CB6-9FC0-266406DF5387 Q36098612-9C0DAF71-BF14-43C7-9178-7F3CD64FA37A Q36111405-2B2A1058-D06D-4A14-8805-A4C5153F83B7 Q36202719-B4FDCCC5-F7CB-47D6-8DB2-310E40FBE163 Q36619447-9429C0F1-9F94-47B5-A471-198140F66B92 Q37358108-6098A2EC-3944-435A-B90A-BEE120850C56 Q38154933-359CF79B-C084-4E85-AE7B-5DF51615738F Q39162354-86BBD229-2F89-4C59-84A5-A2046F16C5AB Q39511094-CB0F5854-892D-4D81-B4DE-6E4C2474B82A Q42724710-E8E1E6BA-06F5-4E6B-9581-D6B8087EC906 Q43650121-AC362F65-1C3D-42C3-87E9-92DC24EF7CD3 Q46532215-5FAAA011-DAC9-434C-9D05-0618997E0AB9

P2860

ADAM12: a potential target for the treatment of chronic wounds

http://www.wikidata.org/entity/Q37173718

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

ADAM12: a potential target for the treatment of chronic wounds

@en

ADAM12: a potential target for the treatment of chronic wounds.

@nl

type

label

ADAM12: a potential target for the treatment of chronic wounds

@en

ADAM12: a potential target for the treatment of chronic wounds.

@nl

prefLabel

ADAM12: a potential target for the treatment of chronic wounds

@en

ADAM12: a potential target for the treatment of chronic wounds.

@nl

P1433

Q37173718-6ABDF5AA-CE18-4768-BEC3-931934099A42

P1476

Q37173718-6074D550-2949-4F24-B900-F3D0C65414CF

P2093

Q37173718-2A155D99-72D4-4BC1-BB63-56CAF70B51ED

Q37173718-2F0E8AD5-E93E-4620-BE0B-F9FB4DC615AF

Q37173718-37C81C44-77D6-48E1-BD2E-D8A5E2B96CC3

Q37173718-37E8867F-3372-495B-A603-8F5040D61E43

Q37173718-496075FD-06CE-4DD8-9678-B31E6BB55A90

Q37173718-50B94D61-1495-4C01-A3E9-4A5614D476A5

Q37173718-9BBD2EF3-6C49-4E3E-A5BA-5EF3A3AE504A

Q37173718-E54F0FB8-37F6-4B5B-A45D-2112409DEF42

P2860

Q37173718-04750B38-785A-4552-A4ED-83BD11D4B271

Q37173718-0F502819-2FB9-46BB-9CFF-E8CC8FB2C560

Q37173718-139A9A63-988A-4123-B75D-7CE7BAD1E1E4

Q37173718-18149C53-4A04-4931-A538-BDC4BD4F06FA

Q37173718-1B1A0651-9274-42F3-8E27-8EAD7D299A6D

Q37173718-1BE6CFA1-8B28-46E3-9BEA-3F16878FA5DD

Q37173718-28E45144-0C1D-422B-8D82-CDA0F183940F

Q37173718-2F41F21F-6D14-4C25-B11F-0F5C3D03B9A6

Q37173718-3156B685-913C-4CBE-B969-AF90BB4B0699

Q37173718-34DF5150-4925-4D62-A0F3-1B8334C8FEE8

P2888

Q37173718-1B03B175-3F6F-4613-BC68-2A2309D9519C

P304

Q37173718-0A4E439E-1F26-48F8-B7B1-FAEFAF5BC7B8

P31

Q37173718-8E6ABD59-F760-4A2D-9F07-D5FFD8F29190

P356

Q37173718-58574087-870A-4B25-BDC7-B900D92C77AB

P433

Q37173718-A6165D12-FC73-43F8-87E9-72004EB2B597

P478

Q37173718-C3D17162-35B5-4019-AD6E-73EA7A9513BF

P50

Q37173718-C77A9656-C1B2-47AF-9058-512DE5629887

P577

Q37173718-B1DC7087-92BD-412A-A741-6D5292AD503E

P5875

Q37173718-450DE0A3-C5A7-4EE0-B9DC-7C622F6D813E

P698

Q37173718-783B1BFC-5B0B-403D-B581-EC5A3BB73985

P932

Q37173718-8B02FD78-7434-43E2-9618-1E0E2B7907B2

P356

S00109-008-0353-Z

P1433

Journal of Molecular Medicine

P1476

ADAM12: a potential target for the treatment of chronic wounds

@en

P2093

Asheesh Harsha

http://www.w3.org/2001/XMLSchema#string

Atsuko Sehara-Fujisawa

http://www.w3.org/2001/XMLSchema#string

Carl P Blobel

http://www.w3.org/2001/XMLSchema#string

Cynthia A Loomis

http://www.w3.org/2001/XMLSchema#string

Harold Brem

http://www.w3.org/2001/XMLSchema#string

Marjana Tomic-Canic

http://www.w3.org/2001/XMLSchema#string

Olivera Stojadinovic

http://www.w3.org/2001/XMLSchema#string

Ulla Wewer

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion

The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading

Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development

Molecular markers in patients with chronic wounds to guide surgical debridement

Understanding and overcoming the challenges of effective case management for patients with chronic wounds

Platelet gel for healing cutaneous chronic wounds

Engineered skin substitutes: practices and potentials

Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy

Protocol for the successful treatment of venous ulcers

ADAMs: key components in EGFR signalling and development

P2888

s00109-008-0353-z

P304

961-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-008-0353-Z

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5247544

http://www.w3.org/2001/XMLSchema#string

P698

18604515

http://www.w3.org/2001/XMLSchema#string

P932

2674959

http://www.w3.org/2001/XMLSchema#string